We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Screening for Memory Studies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01123018
Recruitment Status : Active, not recruiting
First Posted : May 13, 2010
Last Update Posted : August 21, 2015
Information provided by (Responsible Party):

Study Description
Brief Summary:
We hope to recruit participants into various clinical trials and research projects.

Condition or disease Intervention/treatment
Memory Loss Memory Deficits Dementia Behavioral: Memtrax Memory screening test

Detailed Description:
The purpose of this protocol is to advertise, recruit, and do a preliminary screen for various clinical trials. Information collected will be entered in a database available to researchers connected with the Stanford/VA Aging Clinical Research Center, located at VA Palo Alto Health Care System, Palo Alto Division.

Study Design

Study Type : Observational
Estimated Enrollment : 2000 participants
Observational Model: Ecologic or Community
Official Title: Screening for Memory Studies
Study Start Date : June 2007
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Memory
U.S. FDA Resources

Groups and Cohorts

Group/Cohort Intervention/treatment
Older Adults
Persons over age 60
Behavioral: Memtrax Memory screening test
Memory Screening test
Other Name: Memory screening

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   55 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
healthy older adults with memory concerns

Inclusion Criteria:

  • Age 55 or over.

Exclusion Criteria:

  • Major psychiatric problems.
  • Major medical problems.
  • Aversion to test-taking.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01123018

United States, California
VA Palo Alto Health Care System
Palo Alto, California, United States, 94304
Sponsors and Collaborators
Stanford University
VA Office of Research and Development
Principal Investigator: J. Wesson Ashford Jr., MD, PhD Stanford University
More Information

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT01123018     History of Changes
Other Study ID Numbers: SU-06302009-2900
First Posted: May 13, 2010    Key Record Dates
Last Update Posted: August 21, 2015
Last Verified: August 2015

Keywords provided by Stanford University:
Memory Loss

Additional relevant MeSH terms:
Memory Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurocognitive Disorders
Mental Disorders
Neurobehavioral Manifestations
Neurologic Manifestations
Signs and Symptoms